Does DOXORUBICIN Cause Interstitial lung disease? 1,352 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,352 reports of Interstitial lung disease have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 1.6% of all adverse event reports for DOXORUBICIN.
1,352
Reports of Interstitial lung disease with DOXORUBICIN
1.6%
of all DOXORUBICIN reports
150
Deaths
262
Hospitalizations
How Dangerous Is Interstitial lung disease From DOXORUBICIN?
Of the 1,352 reports, 150 (11.1%) resulted in death, 262 (19.4%) required hospitalization, and 52 (3.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 1,352 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
TOCILIZUMAB (1,229)
Which DOXORUBICIN Alternatives Have Lower Interstitial lung disease Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE